Literature DB >> 23306555

A threshold mechanism mediates p53 cell fate decision between growth arrest and apoptosis.

M Kracikova1, G Akiri, A George, R Sachidanandam, S A Aaronson.   

Abstract

The p53 tumor suppressor responds to certain cellular stresses by inducing transcriptional programs that can lead to growth arrest or apoptosis. However, the molecular mechanisms responsible for choosing between these two cell fates are not well understood. Previous studies have suggested that p53 selectively activates proarrest target genes, due to the higher affinity of p53 for their promoters compared with proapoptotic genes. Here we show using microarray and chromatin immunoprecipitation that p53 binds to and transcriptionally activates both its proarrest and proapoptotic target genes proportionally to induced p53 expression levels. Further, we provide evidence that to trigger apoptosis, cells must overcome an apoptotic threshold, whose height is determined by expression levels of p53 and its targets, the duration of their expression and the cellular context. We demonstrate in multiple cells lines that below this threshold, expression levels of p53 and its targets were sufficient to induce arrest but not apoptosis. Above this threshold, p53 and its targets triggered extensive apoptosis. Moreover, lowering this threshold with inhibitors of antiapoptotic Bcl-2 family proteins sensitized cells to p53-induced apoptosis. These findings argue that agents that lower the apoptotic threshold should increase the efficacy of p53-mediated cancer therapy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23306555      PMCID: PMC3595483          DOI: 10.1038/cdd.2012.155

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  48 in total

1.  Analysis of p53-regulated gene expression patterns using oligonucleotide arrays.

Authors:  R Zhao; K Gish; M Murphy; Y Yin; D Notterman; W H Hoffman; E Tom; D H Mack; A J Levine
Journal:  Genes Dev       Date:  2000-04-15       Impact factor: 11.361

2.  Chromatin immunoprecipitation analysis fails to support the latency model for regulation of p53 DNA binding activity in vivo.

Authors:  M D Kaeser; R D Iggo
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-26       Impact factor: 11.205

3.  Global transcriptional program of p53 target genes during the process of apoptosis and cell cycle progression.

Authors:  Asra Mirza; Qun Wu; Luquan Wang; Terri McClanahan; W Robert Bishop; Ferdous Gheyas; Wei Ding; Beth Hutchins; Tish Hockenberry; Paul Kirschmeier; Jonathan R Greene; Suxing Liu
Journal:  Oncogene       Date:  2003-06-05       Impact factor: 9.867

Review 4.  Rethinking clinical trials for cytostatic drugs.

Authors:  Andrew W Millar; Kevin P Lynch
Journal:  Nat Rev Cancer       Date:  2003-07       Impact factor: 60.716

Review 5.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

6.  A polymorphic microsatellite that mediates induction of PIG3 by p53.

Authors:  Ana Contente; Alexandra Dittmer; Manuela C Koch; Judith Roth; Matthias Dobbelstein
Journal:  Nat Genet       Date:  2002-02-04       Impact factor: 38.330

7.  Kinetics of p53 binding to promoter sites in vivo.

Authors:  S T Szak; D Mays; J A Pietenpol
Journal:  Mol Cell Biol       Date:  2001-05       Impact factor: 4.272

Review 8.  Decision making by p53: life, death and cancer.

Authors:  M Oren
Journal:  Cell Death Differ       Date:  2003-04       Impact factor: 15.828

9.  p53 mediates repression of the BRCA2 promoter and down-regulation of BRCA2 mRNA and protein levels in response to DNA damage.

Authors:  Kangjian Wu; Shi-Wen Jiang; Fergus J Couch
Journal:  J Biol Chem       Date:  2003-02-18       Impact factor: 5.157

10.  Treatment with a BH3 mimetic overcomes the resistance of latency III EBV (+) cells to p53-mediated apoptosis.

Authors:  A Pujals; B Renouf; A Robert; S Chelouah; E Hollville; J Wiels
Journal:  Cell Death Dis       Date:  2011-07-28       Impact factor: 8.469

View more
  102 in total

1.  MAPK signaling cascades mediate distinct glucocorticoid resistance mechanisms in pediatric leukemia.

Authors:  Courtney L Jones; Christy M Gearheart; Susan Fosmire; Cristina Delgado-Martin; Nikki A Evensen; Karen Bride; Angela J Waanders; Faye Pais; Jinhua Wang; Teena Bhatla; Danielle S Bitterman; Simone R de Rijk; Wallace Bourgeois; Smita Dandekar; Eugene Park; Tamara M Burleson; Pillai Pallavi Madhusoodhan; David T Teachey; Elizabeth A Raetz; Michelle L Hermiston; Markus Müschen; Mignon L Loh; Stephen P Hunger; Jinghui Zhang; Michael J Garabedian; Christopher C Porter; William L Carroll
Journal:  Blood       Date:  2015-08-31       Impact factor: 22.113

2.  TBP-like Protein (TLP) Disrupts the p53-MDM2 Interaction and Induces Long-lasting p53 Activation.

Authors:  Ryo Maeda; Hiroyuki Tamashiro; Kazunori Takano; Hiro Takahashi; Hidefumi Suzuki; Shinta Saito; Waka Kojima; Noritaka Adachi; Kiyoe Ura; Takeshi Endo; Taka-Aki Tamura
Journal:  J Biol Chem       Date:  2017-01-12       Impact factor: 5.157

3.  CARF (Collaborator of ARF) overexpression in p53-deficient cells promotes carcinogenesis.

Authors:  Rajkumar S Kalra; Caroline T Cheung; Anupama Chaudhary; Jay Prakash; Sunil C Kaul; Renu Wadhwa
Journal:  Mol Oncol       Date:  2015-08-04       Impact factor: 6.603

4.  TP53 Silencing Bypasses Growth Arrest of BRAFV600E-Induced Lung Tumor Cells in a Two-Switch Model of Lung Tumorigenesis.

Authors:  Anny Shai; David Dankort; Joseph Juan; Shon Green; Martin McMahon
Journal:  Cancer Res       Date:  2015-05-22       Impact factor: 12.701

5.  Modeling the response of a tumor-suppressive network to mitogenic and oncogenic signals.

Authors:  Xinyu Tian; Bo Huang; Xiao-Peng Zhang; Mingyang Lu; Feng Liu; José N Onuchic; Wei Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-08       Impact factor: 11.205

Review 6.  Dying to protect: cell death and the control of T-cell homeostasis.

Authors:  Kun-Po Li; Sharmila Shanmuganad; Kaitlin Carroll; Jonathan D Katz; Michael B Jordan; David A Hildeman
Journal:  Immunol Rev       Date:  2017-05       Impact factor: 12.988

7.  Manipulating DNA damage-response signaling for the treatment of immune-mediated diseases.

Authors:  Jonathan P McNally; Scott H Millen; Vandana Chaturvedi; Nora Lakes; Catherine E Terrell; Eileen E Elfers; Kaitlin R Carroll; Simon P Hogan; Paul R Andreassen; Julie Kanter; Carl E Allen; Michael M Henry; Jay N Greenberg; Stephan Ladisch; Michelle L Hermiston; Michael Joyce; David A Hildeman; Jonathan D Katz; Michael B Jordan
Journal:  Proc Natl Acad Sci U S A       Date:  2017-05-22       Impact factor: 11.205

8.  p53 Loses grip on PIK3CA expression leading to enhanced cell survival during platinum resistance.

Authors:  Bhushan Thakur; Pritha Ray
Journal:  Mol Oncol       Date:  2016-06-29       Impact factor: 6.603

9.  MiR-34a suppresses amphiregulin and tumor metastatic potential of head and neck squamous cell carcinoma (HNSCC).

Authors:  Jiali Zhang; Yu Wang; Xinming Chen; Yi Zhou; Fangyan Jiang; Jirong Chen; Li Wang; Wen-Feng Zhang
Journal:  Oncotarget       Date:  2015-04-10

Review 10.  Drugging the p53 pathway: understanding the route to clinical efficacy.

Authors:  Kian Hoe Khoo; Khoo Kian Hoe; Chandra S Verma; David P Lane
Journal:  Nat Rev Drug Discov       Date:  2014-03       Impact factor: 84.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.